In addition, we used the SurvExpress analysis to further assess the prognostic value of TIMP1, ITGA5, FCGR2B, UPP1, ISG20, TSPAN4, and LOXL1 using other glioblastoma patient cohorts, including TCGA Glioblastoma and GSE4412. This evidence concerns the gene TSPAN4 and glioblastoma.